MSK Bone Tumor Notes (Comprehensive)

• Bone tumors can be grouped by tissue type they form: bone-forming, chondroid (cartilage-forming), and other categories (e.g., Ewing sarcoma, chordoma from notochord remnants).

• Important guiding factors when narrowing differential diagnosis:

  • Age of the patient

  • Location on the bone (epiphysis, metaphysis, diaphysis, axial vs appendicular)

  • Radiologic morphology (plain films first; MRI/CT as adjuncts)

  • Histologic appearance and presence/absence of features such as osteoblastic rimming

• Many lesions have benign and malignant counterparts that share histologic traits, making radiologic-pathologic correlation essential.

• Some entities arise in a spectrum (e.g., fibrous cortical defect to non-ossifying fibroma; monostotic vs polyostotic fibrous dysplasia; enchondromas vs chondrosarcomas).

• Genetic and syndromic associations aid diagnosis and risk stratification (e.g., GNAS mutations in fibrous dysplasia; EXT mutations in osteochondromas; IDH mutations in enchondromas; Rankl in giant cell tumors; translocations in Ewing sarcoma).

• The teaching framework used in clinics and MDMs combines clinical presentation, radiology, and pathology to establish the most likely diagnosis and to decide on management.

Bone-forming tumors

• Distribution and origin (anatomic/etiologic):

  • Bone-forming tumors account for roughly ext{30 ext%} of considered bone lesions in the slide context.

  • Unknown origin tumors about ext{20 ext%}; remainder (~ ext{5 ext%}) are notochord-origin tumors.

• Cartilage-forming bone tumors (a bifurcation point):

  • Benign: osteochondroma is the most common benign cartilage-forming tumor.

  • Malignant: conventional chondrosarcoma is the most important malignant cartilage-forming tumor.

• Histology: malignant variants of conventional chondrosarcoma and conventional osteosarcoma are the most common histologic subtypes within their respective precursor lesions.

• Osteoid formation in bone-forming tumors: these tumors produce osteoid; benign examples include osteoid osteoma and osteoid osteoblastoma; malignant example is osteosarcoma.

• Notochordal remnant tumors: chordomas arise in a midline distribution from skull base to sacrum, with a predilection for the clivus.

• Practical clinical take-away: age, bone location, and radiologic/histologic morphology provide crucial clues to differential diagnoses.

Osteoid-forming tumors: benign variants

• Osteoid osteoma

  • Size criterion: ext{< 2 cm}; small nidus with a thick reactive cortical bone rind.

  • Typical location: cortex of long bones (diaphysis or cortical bone);

  • Clinical feature: nocturnal pain relieved by NSAIDs.

  • Radiology: nidus appears radiolucent in center with surrounding sclerotic rind.

  • Treatment: radiofrequency ablation.

  • Malignant transformation risk: rare.

• Osteoid osteoblastoma

  • Size criterion: > ext{2 cm}; more expansive than osteoid osteoma and often involves the posterior elements of the spine (laminae, pedicles).

  • Clinical feature: less responsive to NSAIDs; pain may be more persistent.

  • Radiology: less reactive cortical bone than osteoid osteoma; larger, well-circumscribed lesion.

  • Treatment: curettage or en bloc resection.

  • Malignant transformation risk: rare.

• Key radiologic-pathologic distinctions between osteoid osteoma and osteoblastoma (and how they relate to osteosarcoma):

  • Histology: both show woven bone; benign lesions typically show osteoblastic rimming around woven bone.

  • Malignancy clues: absence of osteoblastic rimming or presence of marked cellular atypia leans toward malignancy (osteosarcoma) in the appropriate context.

  • Size and location help separate benign from malignant processes; small lesions with cortical reaction favor benign osteoid osteoma, larger lesions in posterior elements favor osteoblastoma.

Osteosarcoma (osteogenic sarcoma)

• Definition: a malignant tumor in which cancerous cells produce osteoid matrix or mineralized bone.

• Classification overview (clinical radiology-pathology trifecta):

  • Primary vs secondary osteosarcoma.

  • Intramedullary vs surface types: intramedullary (conventional, low-grade central, telangiectatic, small cell) and surface types (parosteal, periosteal, high-grade surface).

  • Conventional osteosarcoma subtypes: osteoblastic, chondroblastic, fibroblastic (histologic overlap with benign mimics).

• Key take-home points for radiology/pathology integration:

  • Conventional osteosarcoma is the most common subtype.

  • It is typically a metaphyseal lesion of long bones, most commonly around the knee.

  • Radiology shows classic periosteal reactions (e.g., sunburst) and soft-tissue mass; MRI helps determine extent.

  • Histology shows extensive osteoid production by malignant mesenchymal cells.

• Subtype summary (from the referenced table):

  • Conventional osteosarcoma: most common; high-grade; age 10–25; male predilection; intramedullary; most around the knee; histology can be osteoblastic, chondroblastic, or fibroblastic.

  • Low-grade central osteosarcoma: older age; less aggressive but still malignant; central/intramedullary location.

  • Telangiectatic osteosarcoma: high-grade; can mimic aneurysmal bone cysts radiologically; male predilection; around knee.

  • Small cell osteosarcoma: rare; may resemble small cell tumors elsewhere; high-grade.

• Distinguishing a benign lesion from osteosarcoma on imaging/histology:

  • Size, well-defined margins, and benign cytology features favor benign processes.

  • Osteoid production with high-grade cytology and aggressive periosteal reaction supports malignancy.

• Radiographs and imaging philosophy:

  • Plain radiographs often provide the overview snapshot; MRI reveals multifocal disease or soft-tissue extent; radiographs are irreplaceable for initial assessment.

Chondroid (cartilage-forming) tumors

• Benign vs malignant: core distinction is cartilage-forming tumors; malignant form is chondrosarcoma.

• Chondrosarcoma (main points)

  • Most common primary bone sarcoma in adults after multiple myeloma and osteosarcoma.

  • Types:

  • Primary chondrosarcoma: de novo; conventional form accounts for ext{~75 ext%} of cases; graded I–III (low to high grade).

  • Secondary chondrosarcoma: arises in preexisting lesions (en chondroma, osteochondroma, or multifocal cartilaginous lesions).

  • Dedifferentiated chondrosarcoma: dedifferentiates to higher-grade sarcomas (e.g., osteosarcoma, undifferentiated pleomorphic sarcoma, fibrosarcoma).

  • Other rare variants: clear cell, mesenchymal.

  • Epidemiology: conventional chondrosarcoma is most common in adults; peak age typically in the fourth to fifth decades; secondary chondrosarcomas can occur in younger or older patients depending on the precursor.

  • Most ( ext{~90 ext%} ) arise de novo within bone; central/intramedullary location is common; peripheral ~1 ext{%; no true periosteal chondrosarcoma}.

  • Common sites: metaphysis or diaphysis of long bones; loves tubular bones; knees, shoulders; less commonly spine/scapula/sternum; pelvis also common.

  • Matrix and imaging: produces hyaline cartilage; gelatinous or myxoid matrix; lobular growth with endostial scalloping leading to ring-and-arc calcifications on radiographs/CT.

  • Histology and imaging correlation: grade-dependent cellularity, myxoid change, pleomorphism, multinucleated lacunae; the lobular architecture explains the ring-and-arc calcifications.

  • Distinction from enchondromas (benign cartilaginous lesions): radiology relies on cortical involvement, endosteal scalloping, and cortical destruction; enchondromas typically show less aggressive change.

• Enchondroma vs chondrosarcoma (key radiologic distinctions):

  • Enchondroma: endosteal scalloping less than two-thirds of cortical thickness; no periosteal reaction; diaphyseal centric lesions; axial skeleton involvement is uncommon for enchondromas.

  • Chondrosarcoma: endosteal scalloping exceeding 50% of cortical thickness; possible cortical breach or fracture; metaphyseal predilection; axial skeleton involvement more common.

• Central vs peripheral chondrosarcoma: most are central/intramedullary; peripheral excitation is rare.

• Myxoid chondrosarcoma: rare variant; high water content (high T2 signal); can resemble chordoma histologically; location helps differentiate (myxoid tends to be more peripheral; chordomas midline).

• Dedifferentiated and mesenchymal chondrosarcomas: high-grade variants with poorer prognosis; younger patients more likely in mesenchymal type; may involve bone or soft tissue.

• Molecular associations: enchondromas often associated with IDH mutations; osteochondromas with EXT mutations; these genetic features help in diagnosis and therapy planning.

• Practical clinical notes:

  • Conventional chondrosarcoma is the most common adult primary bone sarcoma and a major differential in older adults with cartilaginous tumors.

  • For suspected chondrosarcoma, correlate histology with radiology (e.g., ring-and-arc calcifications, cortical involvement) and consider axial skeleton predilection.

Notochordal remnant tumors: chordomas

• Origin: chordomas arise from notochordal remnants along the midline from skull base to sacrum.

• Common example: clivus involvement in skull-base chordoma.

• Imaging/histology: produce lobulated, destructive midline skull base/sacral lesions with physio-anatomic localization.

• Clinical relevance: important differential in midline skull base and sacral/pelvic lesions.

Ewing sarcoma and the Ewing family tumors (ESFT)

• Epidemiology and clinical features:

  • Ewing sarcoma is the second most common malignant bone tumor in children after osteosarcoma; among pediatric sarcomas, it has the youngest mean age of presentation.

  • Incidence overall: ~ ext{3 ext%} of pediatric cancers; relatively guarded prognosis compared with some bone lesions due to aggressive behavior.

  • Ethnicity/gender: more common in Caucasian males; slight male predilection.

  • Common skeletal sites: predilection for lower limbs; relatively even distribution between femur, ileum, tibia, fibula; pelvis and humerus also involved; ribs and sacrum less common; extraskeletal Ewing’s exists (Askin’s tumor for chest wall).

• ESFT genetics:

  • Most ESFTs harbor characteristic translocations involving EWSR1, e.g., EWS-FLI1; these translocations have implications for familial risk counseling in survivors.

• Clinical presentation and prognosis:

  • Patients present with a painful enlarging mass; fever and systemic symptoms can complicate differentiation from infection.

  • Long-term survivors: morbidity often driven by treatment-related sequelae (chemotherapy-induced myelodysplasia/secondary hematologic malignancies; radiation-related effects).

• Imaging and pathology framework:

  • Skeletal Ewing’s: intramedullary lesion with cortical disruption and periosteal reaction; soft tissue mass may be present; small blue round cell tumor on histology with overlapping features with other small round blue cell tumors (e.g., neuroblastoma).

  • Extraskeletal Ewing’s (Askin tumor is chest wall variant): tends to have a relatively similar histology but different anatomical context; calcification is typically rare in Askin’s tumors.

  • Radiographics 2013 overview emphasizes radiology-pathology correlations, including classic radiologic appearances and histology cross-links.

• Radiologic differential and diagnostic approach:

  • Distinguish Ewing’s from osteomyelitis (infectious signs; ESR elevation; anemia may point toward malignancy).

  • Important radiologic cues include medullary involvement with an ill-defined lesion and large soft tissue component; periosteal reactions may be present but are not specific.

Fibrous dysplasia spectrum and related lesions

• Fibrous dysplasia (FD) basics:

  • FD is a benign bone-forming lesion that expands the medullary cavity, can be monostotic or polyostotic.

  • Pathogenesis is tied to GNAS1 gain-of-function mutations; timing during embryogenesis determines disease extent.

  • Monostotic FD is the most common form; often presents in teens/20s with equal sex distribution; common sites include femur, tibia, and ribs; growth typically ceases at physeal closure.

  • Polyostotic FD occurs earlier and tends to involve the femur and skull; associated syndromes include McCune-Albright syndrome (often unilateral bone lesions with ipsilateral café-au-lait spots and endocrine abnormalities such as GH excess); Masquerade syndrome (rare historical term) may refer to polyostotic FD with unrelated systemic features.

  • Shepherd’s crook deformity describes a characteristic bowing deformity in FD of the femur.

  • Radiology: ground-glass matrix; cortex preserved early; long-axis of lesion parallel to cortex; eccentric epicenter; lesions can be bilateral or multifocal.

  • Histology: storiform/fibrous stroma with curvilinear, “Chinese alphabet” woven bone trabeculae; classic “storiform pattern” helps distinguish from malignant processes; lack of osteoblastic rimming is common in FD because the growth is disordered and not a normal maturation process.

• Fibrous cortical defect (FCD) vs non-ossifying fibroma (NOF) continuum:

  • FCD is the smaller (<3 cm) end of the spectrum; NOF is larger (>3 cm).

  • Both occur in children/teens; NOF is more common in males; lesions are usually metaphyseal/metaphyseal-epiphyseal and near growth plates with posterior/medial cortical involvement in FD context.

  • FD and FCD/NOF spectrum is a common exam concept because radiologic appearance can mimic malignant lesions; they are typically “do not touch” lesions on imaging when clinical and radiographic features fit.

• FD histology and radiology correlation:

  • Fibrous tissue with curvilinear bony trabeculae (often described as Chinese soup-like histology).

  • FD matrix is ground-glass on radiographs and CT; the lesion expands bone but maintains relatively well-defined margins.

Paget’s disease of bone (osteitis deformans)

• Pathophysiology and phases:

  • Three phases: osteolytic (lytic), mixed, and osteoblastic (sclerotic) phases.

  • Lytic phase: osteoclast-mediated resorption; blade-of-grass radiographic appearance is a teaching image (not always seen in real life).

  • Mixed phase: coexisting osteolytic and osteoblastic activity with thickened cortex and trabeculae.

  • Blastic phase: predominantly osteoblastic activity with diffuse sclerosis.

• Epidemiology and common sites:

  • Affects skull, spine, pelvis; pelvic and skull involvement common in radiology practice.

  • Age: typically affects older adults.

• Complications:

  • Sarcomatous transformation occurs in about 3 ext{--}5 ext{ ext%} of Paget’s disease, most commonly to osteosarcoma.

• Practical radiologic clues:

  • Pelvic Paget’s can show diffuse coarsened trabeculae and cortical thickening.

  • In long bones, look for cortical thickening and bone expansion; skull changes include thickened calvaria.

• Exam tip: when long-standing Paget’s is suspected, trace the cortex to look for cortical disruption as a potential sarcoma clue.

Gout and crystal arthropathies

• Gout basics:

  • Crystal arthropathy with urate crystal deposition at joints; first MTP joint is classic for gout.

  • Four phases: asymptomatic hyperuricemia; acute gouty arthritis; intermittent (intercritical) gout with recurrent attacks; chronic tophaceous gout with tophi and potential end-organ damage.

  • Primary gout accounts for about 90 ext{ ext%} of cases; secondary gout (about 10 ext{ ext%}) arises from reduced uric acid secretion (e.g., chronic renal disease) or high turnover states (e.g., certain cancers).

• Complications:

  • Gouty nephropathy and uric acid stones; subcutaneous tophi in multiple sites.

Infections and inflammatory processes in the MSK system

• Spinal infections: pyogenic osteomyelitis vs spinal tuberculosis (Pott disease)

  • Pyogenic osteomyelitis: commonly starts in the metaphysis of children due to blood supply; often involves the disc and end plates in adults; typical organisms include Staphylococcus aureus; other organisms include gram-negative bacteria (e.g., E. coli, Pseudomonas).

  • TB spine (Pott disease): most commonly involves the thoracic spine; disc involvement occurs later; TB can spread subligamentously with epidural abscess; Gibbous deformity (anterior vertebral collapse with kyphosis) is a classic radiologic feature; TB can involve multiple vertebrae with subligamentous spread and cold abscesses.

  • Distinguishing features: TB spine often shows disc sparing early on, vertebral body destruction with subligamentous spread; pyogenic osteomyelitis tends to involve the disc early and can cause rapid systemic symptoms.

• Jaw osteomyelitis and chronic osteomyelitis:

  • Chronic osteomyelitis can be primary (unknown etiology; insidious, low-grade symptoms; in children/adolescents more common) or secondary (common in adults; post dental extraction, caries, trauma).

  • Radiology: sequestrum (necrotic bone), cloaca (draining sinus), involucrum (new periosteal bone around necrotic bone).

  • Radiation-induced osteonecrosis of the jaw: strong association with radiotherapy; dose-dependent; mandible is a common site; gas within bone on imaging is a notable sign.

  • Bisphosphonate-induced osteonecrosis of the jaw: associated with long-term bisphosphonate therapy (osteoporosis or multiple myeloma); typically involves the mandible; history crucial for diagnosis.

• Other pivotal jaw/osteomyelitis references:

  • Garre’s sclerosing osteomyelitis: historical description by Garre; jaw involvement is now recognized more often in clinical radiology practice.

  • Primary chronic osteomyelitis is a non-suppurative inflammatory process; secondary chronic osteomyelitis is often odontogenic in adults.

Aneurysmal bone cysts (ABCs) vs giant cell tumors (GCTs)

• ABCs vs GCTs: important differential due to radiologic and clinical overlap (lytic, cystic lesions in young patients; metaphyseal location in ABCs vs epiphyseal/adult GCTs).

• Age and location:

  • ABCs: typical onset in ages $5 ext{--}20$; metaphyseal predominance; equal gender distribution.

  • GCTs: typically occur in adults with closed physes; commonly around the knee; more common in females than males.

• Genetics and behavior:

  • ABC: associated with a translocation involving chromosome 17p (gene not specified here) in many cases.

  • GCT: mononuclear cells express RANKL; targeted therapy with anti-RANKL agents (denosumab) used in management.

• Radiology mnemonic: ABCs contain osteoblasts and blood-filled cystic spaces; GCTs contain osteoclast-like giant cells in a fibrous stroma with potential foamy histology.

• Practical takeaway: age is a practical first discriminator on radiographs; metaphyseal location suggests ABC in younger patients, while a lesion around the knee in an adult with epiphyseal involvement suggests GCT.

Osteochondroma vs enchondroma: benign cartilaginous lesions

• Osteochondroma (exostosis):

  • Origin: exophytic lesion arising from cortex with cartilage cap; continuity of bone marrow and cortex with parent bone.

  • Typical location: bones of endochondral origin; commonly metaphysis of long bones (e.g., distal femur, proximal tibia); occasional involvement of pelvis, scapula, ribs.

  • Genetics: EXT mutations; may be solitary or multiple (hereditary multiple osteochondromas).

  • Clinical relevance: generally benign; multiple lesions raise concern for malignant transformation to chondrosarcoma.

• Enchondroma (intraosseous chondroma):

  • Location: medullary space; commonly in bones formed by endochondral ossification; hands and feet (metaphyseal regions of tubular bones) are frequent sites.

  • Genetic associations: IDH mutations in chondromas.

• Distinguishing features radiologically:

  • Osteochondroma: exophytic growth with a cartilaginous cap; continuous cortex and medullary canal with parent bone.

  • Enchondroma: medullary center-based lesion with smooth scalloping; no exophytic growth.

• Malignant transformation risk:

  • Osteochondromas: risk increases with multifocal disease; potential transformation to chondrosarcoma.

  • Enchondromas: syndromic cases (e.g., Ollier disease) have higher risk of malignant transformation to chondrosarcoma.

• Take-home points for exams and radiology:

  • Differentiating feature is the location and relation to cortex: exophytic vs medullary-centered.

  • Location origin and growth pattern help separate the two; look for cartilage cap in osteochondroma.

Practical radiology-pathology framework and exam approach

• The value of a three-pronged approach: clinical presentation, radiology, and pathology form a trifecta for most bone tumors.

• Plain radiographs are foundational; MRI/CT provide extent and matrix details; radiology-pathology correlations (as in classic Radiographics articles) help cement interpretation.

• Size, margins, cortical reaction, periosteal reaction, and soft tissue involvement are key imaging clues.

• Do not forget red flags suggesting malignancy: rapid growth, cortical destruction, soft tissue mass, and new pain.

• Always consider age and location first in differential diagnosis; these often drive the most likely tumor before imaging is fully interpreted.

Quick reference: key numeric anchors and qualitative signals

• Percentages (from transcript context):

  • Bone-forming tumors: ≈ 30 ext{ ext%}

  • Unknown origin tumors: ≈ 20 ext{ ext%}

  • Notochord-origin tumors: ≈ 5 ext{ ext%}

• Osteoid-forming tumor size distinction:

  • Osteoid osteoma: < 2 ext{ cm}

  • Osteoid osteoblastoma: > 2 ext{ cm}

• Osteosarcoma conventional subtype: the most common histology among conventional osteosarcomas; usually high-grade; knee region around the knee is most common location; age distribution skewed toward children/young adults.

• Chondrosarcoma conventional subtype: ≈ 75 ext{ ext%} of all chondrosarcomas; most are central/intramedullary; peak adult age around the $fourth ext{–}fifth decade$; secondary ~10 ext{ ext%} from enchondromas/osteochondromas.

• Enchondroma vs chondrosarcoma radiologic cues:

  • Enchondroma: endosteal scalloping < ⅔ cortical thickness; no periosteal reaction; diaphyseal location; medullary center.

  • Chondrosarcoma: endosteal scalloping > ½ cortical thickness; possible cortical breach; metaphyseal predilection; axial skeleton involvement more common.

• Paget’s disease phases and complications:

  • Lytic → mixed → blastic phases; sarcomatous transformation risk ext{3–5%}; blade-of-grass lytic appearance is a teaching cue.

• Ewing sarcoma age window: peak around $10 ext{–}15$ years; highest risk in pediatric population; extraskeletal forms and Askin’s tumor variations exist; prognosis tied to stage and response to therapy.

• FD spectrum: monostotic vs polyostotic; McCune–Albright syndrome features (ipsilateral cafe-au-lait spots with endocrinopathies); GNAS mutation timing correlates with disease extent.

Study tips for exams and clinical practice

• Build a three-pronged framework for each lesion: define the lesion (benign/malignant), note the typical age group and location, and memorize the hallmark imaging and histology features.

• Develop the habit of starting with plain radiographs, then add MRI/CT features to flesh out the differential.

• When comparing similar lesions (e.g., enchondroma vs chondrosarcoma; ABC vs GCT; osteoid osteoma vs osteoblastoma), anchor the decision on size, location, and degree of cortical involvement.

• Use tables and visual exemplars (as suggested by the speaker) to compare entities side-by-side and cement connections between radiology and histology.

• Be ready to discuss not only the diagnosis but also prognosis, typical treatment approaches (e.g., radiofrequency ablation for osteoid osteoma; curettage for osteoblastoma; chemotherapy/radiation considerations for Ewing’s), and important complications (e.g., secondary sarcomas in Paget’s disease; therapy-related morbidities in ESFT).

Keyまとめ (summary for quick recall)

• Bone-forming tumors: osteoid osteoma, osteoid osteoblastoma, osteosarcoma (conventional and variants).

• Chondroid tumors: enchondroma vs chondrosarcoma; conventional chondrosarcoma is most common in adults; understand ring-and-arc calcifications and endosteal scalloping patterns.

• Ewing sarcoma: pediatric-prone malignant tumor; intramedullary origin with possible soft tissue mass; ESFT and Askin’s tumor variants exist; beware mimics such as osteomyelitis and TB.

• Fibrous dysplasia and FCD/NOF: spectrum of benign fibro-osseous lesions; GNAS mutations; radiologic ground-glass matrix; histology storiform bone with curvilinear trabeculae; do not over-biopsy when classic features fit.

• Paget’s disease: tri-phasic bone remodeling with lytic, mixed, and blastic phases; potential sarcomatous transformation; blade-of-grass appearance and coarse trabeculae are classic radiographic cues.

• Infections: TB spine vs pyogenic osteomyelitis; subligamentous spread in TB; Gibbous deformity; jaw osteomyelitis patterns (sequestrum, cloaca, involucrum).

• Gout and crystal arthropathies: clinical phases and renal complications; MTP1 involvement is classic; chronic tophaceous disease with systemic implications.

• Integration: always consider age, location, and matrix type (bone vs cartilage) when forming differential diagnoses; histology and radiology must be interpreted in the clinical context; a clinical-radiological-pathological framework yields the safest and most accurate radiology reports.